Apollomics, Inc. (APLM) vs BioStem Technologies, Inc. (BSEM)
A side-by-side comparison of Apollomics, Inc. and BioStem Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$23.00HealthcareDelayed quote: Oct 5, 2026, 3:59 PM EDT
BSEM
BioStem Technologies, Inc.
$2.76HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — APLM vs BSEM
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)BSEM +162.9% (+21.3%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
APLM BSEM
APLM vs BSEM: by the numbers
- •APLM is the larger company ($51M vs $47M market cap).
- •Both run net losses; BSEM's is the smaller (-13.86% vs -128.69% net margin).
Metrics side by side
Valuation
| Metric | APLM | BSEM |
|---|---|---|
| P/B ratio | N/A | 1.69 |
Profitability
| Metric | APLM | BSEM |
|---|---|---|
| Gross margin | 97.00% | 93.13% |
| Operating margin | -111.45% | -1.45% |
| Net margin | -128.69% | -13.86% |
| ROE | N/A | -102.45% |
| ROIC | -2441.49% | -80.92% |
Growth (annualized)
| Metric | APLM | BSEM |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
| Total return CAGR (5Y) | N/A | 15.72% |
Go deeper
Dig into the metrics
Apollomics ROEBioStem Technologies ROEApollomics operating marginBioStem Technologies operating marginApollomics revenue growthBioStem Technologies revenue growthApollomics free cash flowBioStem Technologies free cash flow
Apollomics & BioStem Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.